scout
|Videos|June 16, 2017

The Complexity of the PARP Inhibitor Landscape in Ovarian Cancer

Douglas A. Levine, MD, professor, Department of Obstetrics and Gynecology, and director, Divison of Gynecologic Oncology, NYU Langone Medical Center, discusses the impact of PARP inhibitors on the landscape of ovarian cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME